Abstract
In this paper the various BBB systems have been described including the various isolation procedures of brain capillary endothelial cells (BCEC), the culture of monolayers of BCEC and endothelial cell lines, and the coculture of BCEC with various types of astrocytes. The transference of results between BBB culture systems has been discussed together with the application of the various BCEC co-culture systems in research. It is concluded that there is a need for interlaboratory validation of BBB data, particularly BBB transport data.
Keywords: Blood-Brain Barrier, BBB Cultures
Current Medicinal Chemistry - Central Nervous System Agents
Title: In Vitro Models of the Blood-Brain Barrier: When to Use Which?
Volume: 2 Issue: 3
Author(s): A(Bert). G. de Boer and P. J. Gaillard
Affiliation:
Keywords: Blood-Brain Barrier, BBB Cultures
Abstract: In this paper the various BBB systems have been described including the various isolation procedures of brain capillary endothelial cells (BCEC), the culture of monolayers of BCEC and endothelial cell lines, and the coculture of BCEC with various types of astrocytes. The transference of results between BBB culture systems has been discussed together with the application of the various BCEC co-culture systems in research. It is concluded that there is a need for interlaboratory validation of BBB data, particularly BBB transport data.
Export Options
About this article
Cite this article as:
de Boer G. A(Bert). and Gaillard J. P., In Vitro Models of the Blood-Brain Barrier: When to Use Which?, Current Medicinal Chemistry - Central Nervous System Agents 2002; 2 (3) . https://dx.doi.org/10.2174/1568015023358012
DOI https://dx.doi.org/10.2174/1568015023358012 |
Print ISSN 1568-0150 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6158 |
Related Articles
-
New Prospects for Nelfinavir in Non-HIV-Related Diseases
Current Molecular Pharmacology A Review on Exploring the Opportunities of Polymer Drug Conjugated Systems for Targeted Cancer Treatment
Current Drug Delivery Techniques to Investigate Neuronal Mitochondrial Function and its Pharmacological Modulation
Current Drug Targets Biosynthetic Pathways to Glycosidase Inhibitors
Current Chemical Biology A 1536-Well Fluorescence Polarization Assay to Screen for Modulators of the MUSASHI Family of RNA-Binding Proteins
Combinatorial Chemistry & High Throughput Screening Novel Targeting of Apoptosis Pathways for Prostate Cancer Therapy
Current Cancer Drug Targets Potential Cardio-Protective Agents: A Resveratrol Review (2000-2019)
Current Pharmaceutical Design ErbB Antagonists Patenting: “Playing Chess with Cancer”
Recent Patents on Biotechnology EGFR-Targeting Monoclonal Antibodies in Head and Neck Cancer
Current Cancer Drug Targets Adenovirus Vectors Composed of Subgroup B Adenoviruses
Current Gene Therapy RAS/RAF/MEK Inhibitors in Oncology
Current Medicinal Chemistry Anti-MDR Effects of Quercetin and its Nanoemulsion in Multidrug-Resistant Human Leukemia Cells
Anti-Cancer Agents in Medicinal Chemistry Recent Patents on Light Based Therapies: Photodynamic Therapy, Photothermal Therapy and Photoimmunotherapy
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Targeting Glioblastoma: The Current State of Different Therapeutic Approaches
Current Neuropharmacology Crude Venom from Nematocysts of the Jellyfish Pelagia noctiluca as a Tool to Study Cell Physiology
Central Nervous System Agents in Medicinal Chemistry Novel Phospholipid-Based Labrasol Nanomicelles Loaded Flavonoids for Oral Delivery with Enhanced Penetration and Anti-Brain Tumor Efficiency
Current Drug Delivery The Current WHO Classification of Tumours of the Central Nervous System: Histopathology and Additional Diagnostic Methods
Current Medical Imaging Virtual Screening of Acetylcholinesterase Inhibitors Based on Machine Learning Combined with Molecule Docking Methods
Current Bioinformatics The Evolving Landscape in the Development of Isocitrate Dehydrogenase Mutant Inhibitors
Mini-Reviews in Medicinal Chemistry Immunotherapy of Malignant Gliomas Using Autologous and Allogeneic Tissue Cells
Anti-Cancer Agents in Medicinal Chemistry